Literature DB >> 7329891

Mexiletine in human blood and breast milk.

A M Lewis, L Patel, A Johnston, P Turner.   

Abstract

Twelve paired samples of breast milk and blood were obtained, between the 2nd and 5th days after she had given birth, from a 30-year-old woman who was a 8-hourly propranolol (20 mg) and mexiletine (200 mg). Propranolol was detected in 9 of the samples of blood and in only 4 of the milk samples. Mexiletine was measurable in all samples, and the milk : plasma ratio varied between 0.79 and 1.89 with a mean of 1.45. However, the large volume of distribution of mexiletine makes it unlikely that the small dose of the drug received from the milk would be detrimental to the health of infants.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7329891      PMCID: PMC2426155          DOI: 10.1136/pgmj.57.671.546

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Mexiletine for control of ventricular dysrhythmias in pregnancy.

Authors:  A D Timmis; G Jackson; D W Holt
Journal:  Lancet       Date:  1980-09-20       Impact factor: 79.321

2.  Paediatric use of mexiletine and disopyramide.

Authors:  D W Holt; A C Walsh; P V Curry; M Tynan
Journal:  Br Med J       Date:  1979-12-08

Review 3.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

4.  Propranolol in human plasma and breast milk.

Authors:  J H Bauer; B Pape; J Zajicek; T Groshong
Journal:  Am J Cardiol       Date:  1979-04       Impact factor: 2.778

  4 in total
  7 in total

1.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 2.  Maternal cardiac arrhythmias during pregnancy and lactation.

Authors:  Rachael Cordina; Mark A McGuire
Journal:  Obstet Med       Date:  2010-03-04

Review 3.  Clinical pharmacokinetics of mexiletine.

Authors:  L Labbé; J Turgeon
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

Review 4.  Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  J P Monk; R N Brogden
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

5.  Disopyramide and its N-monodesalkyl metabolite in breast milk.

Authors:  D B Barnett; S A Hudson; A McBurney
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 6.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 7.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.